As of January 22, 2025, Fractyl Health (GUTS) has a market cap of $90.426 million USD. According to our data, Fractyl Health is ranked No.7758 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $90.43 M |
-8.74%
|
Dec 31, 2024 | $99.08 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
DexCom
DXCM
|
$34.02 B |
-0.000 M
|
USA
|
Medtronic
MDT
|
$112.64 B |
0.001 M
|
Ireland
|
Insulet
PODD
|
$19.56 B |
0.000 M
|
USA
|
Tandem Diabetes Care
TNDM
|
$2.30 B |
0.000 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Novo Nordisk
NVO
|
$335.24 B |
64.098 B
|
Denmark
|
Eli Lilly
LLY
|
$678.07 B |
0.022 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.75 B |
0.001 M
|
USA
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Pfizer
PFE
|
$147.40 B |
-0.003 M
|
USA
|
Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
Market Cap | = | GUTS Stock Price | * | GUTS Shares Outstanding |
= | $1.88 | * | 48.10 M | |
= | $90.43 M |